Participants in the Genetics Expert Network for Enterprises consortium, which is due to be wound up, want a successor body to continue its contribution to the 100,000 Genomes Project.
In a blog post on 28 July, Genomics England’s commercial director Joanne Hackett said that removing barriers between academia, industry, government and the NHS had been “one of the most innovative aspects of GENE”, and she called for a new body to be established to continue this work.
“Breaking these silos helps us to better understand the processes needed to turn pioneering discoveries into practical treatments that can be rapidly adopted in routine care,” Hackett wrote.